MANEA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.774600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.009000E-01
Normal-vs-Stage2
6.600200E-01
Normal-vs-Stage3
1.583040E-01
Normal-vs-Stage4
3.087200E-01
Stage1-vs-Stage2
4.157400E-01
Stage1-vs-Stage3
1.677030E-01
Stage1-vs-Stage4
2.900400E-01
Stage2-vs-Stage3
3.677800E-01
Stage2-vs-Stage4
2.308800E-01
Stage3-vs-Stage4
1.801230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.871200E-01
Normal-vs-AfricanAmerican
9.709400E-01
Normal-vs-Asian
3.824800E-01
Caucasian-vs-AfricanAmerican
8.132000E-01
Caucasian-vs-Asian
1.773630E-01
AfricanAmerican-vs-Asian
2.222800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.142000E-01
Normal-vs-Female
9.613800E-01
Male-vs-Female
4.862200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.772200E-01
Normal-vs-Age(41-60Yrs)
9.209200E-01
Normal-vs-Age(61-80Yrs)
8.287400E-01
Normal-vs-Age(81-100Yrs)
4.946000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.875800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.221600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.205800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.652400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.344000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.752600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.485600E-01
Normal-vs-Daily Drinker
2.050200E-01
Normal-vs-Weekly Drinker
4.727600E-01
Normal-vs-Occasional Drinker
6.109800E-01
Normal-vs-Social Drinker
9.639000E-01
Non Drinker-vs-Daily Drinker
2.780600E-01
Non Drinker-vs-Weekly Drinker
9.572400E-01
Non Drinker-vs-Occasional Drinker
7.230100E-02
Non Drinker-vs-Social Drinker
3.657600E-01
Daily Drinker-vs-Weekly Drinker
4.043800E-01
Daily Drinker-vs-Occasional Drinker
3.146000E-02
Daily Drinker-vs-Social Drinker
1.303040E-01
Weekly Drinker-vs-Occasional Drinker
7.775600E-02
Weekly Drinker-vs-Social Drinker
3.951200E-01
Occasional Drinker-vs-Social Drinker
2.512000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.592000E-01
Normal-vs-Grade 2
1.964250E-01
Normal-vs-Grade 3
2.096200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.223200E-01
Grade 1-vs-Grade 3
5.671800E-01
Grade 1-vs-Grade 4
2.592000E-01
Grade 2-vs-Grade 3
7.213400E-01
Grade 2-vs-Grade 4
1.964250E-01
Grade 3-vs-Grade 4
2.096200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.877400E-01
Normal-vs-NonDiabetic
5.663800E-01
Diabetic-vs-NonDiabetic
3.619000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.523600E-02
Normal-vs-NoPancreatitis
8.515400E-01
Pancreatitis-vs-NoPancreatitis
1.162540E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.364200E-01
Normal-vs-N1
8.102200E-01
N0-vs-N1
6.086800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.248400E-01
Normal-vs-TP53-NonMutant
9.125200E-01
TP53-Mutant-vs-TP53-NonMutant
4.949000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
